Sound waves smash heart artery calcium in new trial
NCT ID NCT07512206
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the Shockwave C2 Aero, which uses sound waves to break up calcium deposits in heart arteries before placing a stent. About 200 people with coronary artery disease will be enrolled across 8 U.S. sites. The goal is to see if the device works safely and effectively in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) System (a device that uses sound waves to break up calcium in heart arteries)
- What this could lead to
- If successful, this device could offer a safer, more effective way to treat heavily calcified coronary arteries, potentially reducing complications and improving long-term heart health.
- What could go wrong
- This is a small, early-stage study (200 people) without a comparison group, so results may not apply to everyone. Risks include artery damage, heart attack, or the device failing to work as intended.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Scott & White Health - The Heart Hospital Plano
Plano, Texas, 75093, United States
-
Good Samaritan University Hospital
West Islip, New York, 11795, United States
-
Henry Ford St. John Hospital
Detroit, Michigan, 48236, United States
-
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
-
Los Robles Regional Medical Center
Thousand Oaks, California, 91360, United States
-
St Francis Hospital & Heart Center
Roslyn, New York, 11576, United States
-
The Valley Hospital
Paramus, New Jersey, 07652, United States
-
WellSpan Health, York Hospital
York, Pennsylvania, 17403, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict which heart blockages will worsen after stenting?
- Can a drop of blood predict disease years before it strikes?
- Can a new catheter make heart stenting safer and more effective?
- Heart rehab may tweak cell death pathways — a study investigates
- Can a trained eye match ultrasound for heart stent placement?
- Heart pump may help High-Risk patients get Life-Saving artery treatment